Back to search

Article

Resistance of SARS-CoV-2 Omicron Subvariant BA.4.6 to Antibody Neutralization

2022-09-06

Abstract excerpt

SARS-CoV-2 Omicron subvariants BA.4.6, BA.4.7, and BA.5.9 have recently emerged, and BA.4.6 appears to be expanding even in the presence of BA.5 that is globally dominant. Compared to BA.5, these new subvariants harbor a mutation at R346 residue in the spike glycoprotein, raising concerns for further antibody evasion. We compared the viral receptor binding affinity of the new Omicron subvariants with BA.5 by surfa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
082d298d-fcf0-5ba0-907f-fe791ec9a145
DOI
10.1101/2022.09.05.506628
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Resistance of SARS-CoV-2 Omicron Subvariant BA.4.6 to Antibody NeutralizationDOI 10.1101/2022.09.05.506628
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5Semantic proximity
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5.Semantic proximity
SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasionSemantic proximity
Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75Semantic proximity
Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3Semantic proximity
Exposure to BA.4/BA.5 Spike glycoprotein drives pan-Omicron neutralization in vaccine-experienced humans and miceSemantic proximity
Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2Semantic proximity
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesSemantic proximity
Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1Semantic proximity
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.Semantic proximity
Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineagesSemantic proximity
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2.Semantic proximity
Select a neighboring publication to make it the new centre.